Treating periodontal disease may reduce prostate inflammation
the ONA take:
According to a new report published in the journal Dentistry, researchers from Case Western Reserve University School of Dental Medicine and the Departments of Urology and Pathology at University Hospitals Case Medical Center in Cleveland, Ohio, have found that treating gum disease reduced symptoms of prostate inflammation.
For the study, researchers enrolled 27 men with confirmed inflammation of the prostate gland and elevated prostate specific antigen (PSA) levels.
All of the men also had moderate to severe gum disease. Of the 27 participants, 21 had no or mild inflammation, 15 had biopsy-confirmed malignancies, and two had inflammation and malignancy. All were then treated for periodontal disease.
Results showed that despite receiving no prostate treatment, 21 of the 27 participants had decreased PSA levels. Researchers found that those with the highest levels of prostate inflammation benefited the most from gum disease treatment.
"This study shows that if we treat the gum disease, it can improve the symptoms of prostatitis and the quality of life for those who have the disease," said Nabil Bissada, chair of Case Western Reserve's Department of Periodontics and the new study's corresponding author.
Treating gum disease reduced symptoms of prostate inflammation.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
- Exercise May Mitigate Cardiotoxicity Associated With Doxorubicin Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|